PRESS STATEMENT

A new report from the Altarum Institute found that from July 2014 to July 2015, price growth for prescription drug spending was considerably higher than any other health category. In response, John Rother, president of the National Coalition on Health Care and leader of the Campaign for Sustainable Rx Pricing, issued the following statement:

“This latest health care price growth report indicates that spending on pricey prescription medications shows no sign of slowing down. When compared to other health care services, it is clear that high cost treatments continue to top the charts as a serious threat to the sustainability of our health care system and beyond. Now is the time for all stakeholders – including the pharmaceutical industry – to find solutions to curb these costs before it’s too late.”